Phase II study of 7 days on/7 days off temozolomide in patients with high-grade glioma.

Trial Profile

Phase II study of 7 days on/7 days off temozolomide in patients with high-grade glioma.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2014

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma; Gliosarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top